Researchers have designed an mRNA vaccine that delayed the onset of and reduced the severity of multiple sclerosis-like disease in mice.
The vaccine restores the body’s tolerance to its own proteins, suppressing the disease's immune over reactivity...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.